Preoperative systemic chemotherapy does not benefit for appendiceal pseudomyxoma peritonei.

Rui-Qing MaDongmei LuShilin XueXiwen FanXichao ZhaiChong WangHongbin XuShaojun Pang

Published in: ANZ journal of surgery (2022)

PSC does not increase the risk of major perioperative complications in patients with appendiceal PMP, but it also does not bring postoperative survival benefits to patients either.

Keyphrases

patients undergoing
low grade
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
cardiac surgery
prognostic factors
peritoneal dialysis
squamous cell carcinoma
radiation therapy
patient reported outcomes
acute kidney injury
locally advanced
rectal cancer